Caricamento...
Intranasal rifampicin for Alzheimer's disease prevention
INTRODUCTION: Oral rifampicin has been shown to significantly reduce amyloid β (Aβ) and tau pathologies in mice. However, it shows occasional adverse effects such as liver injury in humans, making its use difficult for a long period. METHODS: To explore safer rifampicin treatment, APP(OSK) mice, a m...
Salvato in:
| Pubblicato in: | Alzheimers Dement (N Y) |
|---|---|
| Autori principali: | , , , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Elsevier
2018
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6076366/ https://ncbi.nlm.nih.gov/pubmed/30094330 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.trci.2018.06.012 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|